General Manager, New Ventures
Wed, Feb 23, 2022
Feb 23
exercised or converted securities in EXAS
10,197 shares @ $0.00
Decreased holdings by -100.00%
Net across this filing: +57.30% (+5,480 shares)
Option Exercise
Sale tied to a same-time option exercise
EXASEXACT SCIENCES CORP
Health CareHealth Care Services